Intra-Cellular Debt Current Trend from 2010 to 2022

ITCI
 Stock
  

USD 51.50  2.31  4.29%   

Intra-Cellular Ther Debt Current is increasing over the last several years with slightly volatile swings. Debt Current is predicted to flatten to about 6.5 M. During the period from 2010 to 2022 Intra-Cellular Ther Debt Current regressed destribution of quarterly values had coefficient of variationof 35.28 and r-squared of  0.54. Intra-Cellular Ther Operating Expenses is most likely to increase significantly in the upcoming years. The last year's value of Operating Expenses was reported at 361.46 Million. The current Revenues is estimated to increase to about 90.4 M, while Consolidated Income is projected to decrease to (291.6 M).
  
Check Intra-Cellular Ther financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intra-Cellular main balance sheet or income statement drivers, such as Direct Expenses of 8.7 M, Cost of Revenue of 7.1 M or Gross Profit of 81.8 M, as well as many exotic indicators such as Calculated Tax Rate of 0.52, PPandE Turnover of 47.73 or Receivables Turnover of 6.23. Intra-Cellular financial statements analysis is a perfect complement when working with Intra-Cellular Ther Valuation or Volatility modules. It can also supplement Intra-Cellular Ther's financial leverage analysis and stock options assessment as well as various Intra-Cellular Ther Technical models . Please see the analysis of Intra-Cellular Ther Correlation against competitors.

Intra-Cellular Ther Quarterly Debt Current

7.74 Million

Intra-Cellular Debt Current Breakdown

Showing smoothed Debt Current of Intra-Cellular Ther with missing and latest data points interpolated. The current portion of Total Debt; reported if the company operates a classified balance sheet that segments current and non-current liabilities.Intra-Cellular Ther's Debt Current historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intra-Cellular Ther's overall financial position and show how it may be relating to other accounts over time.
Debt Current10 Years Trend
Increasing
Slightly volatile
   Debt Current   
Share
       Timeline  

Intra-Cellular Debt Current Regression Statistics

Arithmetic Mean 3,898,081
Geometric Mean 3,722,543
Coefficient Of Variation 35.28
Mean Deviation 1,093,302
Median 3,187,435
Standard Deviation 1,375,191
Range 3,544,565
R-Value 0.73
R-Squared 0.54
Significance 0.004279
Slope 259,215

Intra-Cellular Debt Current History

20205.5 M
20216.7 M
20226.5 M

About Intra-Cellular Ther Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Intra-Cellular Ther income statement, its balance sheet, and the statement of cash flows. Intra-Cellular Ther investors use historical funamental indicators, such as Intra-Cellular Ther's Debt Current, to determine how well the company is positioned to perform in the future. Although Intra-Cellular Ther investors may use each financial statement separately, they are all related. The changes in Intra-Cellular Ther's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intra-Cellular Ther's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Intra-Cellular Ther Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Intra-Cellular Ther. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Debt Current6.7 M6.5 M
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Intra-Cellular Ther without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Intra-Cellular Ther using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Intra-Cellular Ther Correlation against competitors. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
1.77
Return On Assets
-0.28
Return On Equity
-0.5
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.